Literature DB >> 30244065

Rethinking the classification of alopecia areata.

Carlos G Wambier1, Brett A King2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30244065     DOI： 10.1016/j.jaad.2018.08.059

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

2.  Development of the Scalp Hair Assessment PRO™ measure for alopecia areata.

Authors:  K W Wyrwich; H Kitchen; S Knight; N V J Aldhouse; J Macey; F P Nunes; Y Dutronc; N Mesinkovska; J M Ko; B A King
Journal:  Br J Dermatol       Date:  2020-05-26       Impact factor: 9.302

Review 3.  Defining Severity in Alopecia Areata: Current Perspectives and a Multidimensional Framework.

Authors:  Brett A King; Maryanne M Senna; Manabu Ohyama; Antonella Tosti; Rodney D Sinclair; Susan Ball; Justin M Ko; Marc Glashofer; Rodrigo Pirmez; Jerry Shapiro
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-31

4.  Characterizing the relationships between patient-reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib.

Authors:  R Winnette; A Banerjee; V Sikirica; E Peeva; K Wyrwich
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-01-25       Impact factor: 9.228

5.  The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.

Authors:  K W Wyrwich; H Kitchen; S Knight; N V J Aldhouse; J Macey; F P Nunes; Y Dutronc; N Mesinkovska; J M Ko; B A King
Journal:  Br J Dermatol       Date:  2020-04-03       Impact factor: 9.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.